FR2205329A1 - - Google Patents

Info

Publication number
FR2205329A1
FR2205329A1 FR7339182A FR7339182A FR2205329A1 FR 2205329 A1 FR2205329 A1 FR 2205329A1 FR 7339182 A FR7339182 A FR 7339182A FR 7339182 A FR7339182 A FR 7339182A FR 2205329 A1 FR2205329 A1 FR 2205329A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7339182A
Other languages
French (fr)
Other versions
FR2205329B1 (US20100012521A1-20100121-C00001.png
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Robapharm AG
Original Assignee
Robapharm AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robapharm AG filed Critical Robapharm AG
Publication of FR2205329A1 publication Critical patent/FR2205329A1/fr
Application granted granted Critical
Publication of FR2205329B1 publication Critical patent/FR2205329B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55Acids; Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7339182A 1972-11-04 1973-11-05 Expired FR2205329B1 (US20100012521A1-20100121-C00001.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5092472A GB1448366A (en) 1972-11-04 1972-11-04 Pharmaceutical compositions containing styrylpyridine derivatives

Publications (2)

Publication Number Publication Date
FR2205329A1 true FR2205329A1 (US20100012521A1-20100121-C00001.png) 1974-05-31
FR2205329B1 FR2205329B1 (US20100012521A1-20100121-C00001.png) 1976-07-02

Family

ID=10457952

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7339182A Expired FR2205329B1 (US20100012521A1-20100121-C00001.png) 1972-11-04 1973-11-05

Country Status (13)

Country Link
JP (1) JPS49132078A (US20100012521A1-20100121-C00001.png)
AU (1) AU6218673A (US20100012521A1-20100121-C00001.png)
BE (1) BE806871A (US20100012521A1-20100121-C00001.png)
BG (1) BG20558A3 (US20100012521A1-20100121-C00001.png)
DD (1) DD107919A5 (US20100012521A1-20100121-C00001.png)
DE (1) DE2355195A1 (US20100012521A1-20100121-C00001.png)
ES (1) ES420221A1 (US20100012521A1-20100121-C00001.png)
FR (1) FR2205329B1 (US20100012521A1-20100121-C00001.png)
GB (1) GB1448366A (US20100012521A1-20100121-C00001.png)
HU (1) HU167662B (US20100012521A1-20100121-C00001.png)
IL (1) IL43550A0 (US20100012521A1-20100121-C00001.png)
NL (1) NL7315093A (US20100012521A1-20100121-C00001.png)
ZA (1) ZA738505B (US20100012521A1-20100121-C00001.png)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2445319A1 (fr) * 1978-12-28 1980-07-25 Ono Pharmaceutical Co Derives de pyridine, procedes pour leur preparation et compositions pharmaceutiques les contenant

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3580909A (en) * 1968-12-09 1971-05-25 Hoffmann La Roche 4-styrylpyridines

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3580909A (en) * 1968-12-09 1971-05-25 Hoffmann La Roche 4-styrylpyridines

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2445319A1 (fr) * 1978-12-28 1980-07-25 Ono Pharmaceutical Co Derives de pyridine, procedes pour leur preparation et compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
NL7315093A (US20100012521A1-20100121-C00001.png) 1974-05-07
BE806871A (fr) 1974-04-30
AU6218673A (en) 1975-05-08
ZA738505B (en) 1974-09-25
DE2355195A1 (de) 1974-05-16
HU167662B (US20100012521A1-20100121-C00001.png) 1975-11-28
ES420221A1 (es) 1976-03-16
GB1448366A (en) 1976-09-08
IL43550A0 (en) 1974-03-14
BG20558A3 (US20100012521A1-20100121-C00001.png) 1975-12-05
FR2205329B1 (US20100012521A1-20100121-C00001.png) 1976-07-02
JPS49132078A (US20100012521A1-20100121-C00001.png) 1974-12-18
DD107919A5 (US20100012521A1-20100121-C00001.png) 1974-08-20

Similar Documents

Publication Publication Date Title
JPS4942494A (US20100012521A1-20100121-C00001.png)
JPS4946440A (US20100012521A1-20100121-C00001.png)
JPS4920694A (US20100012521A1-20100121-C00001.png)
JPS4969867A (US20100012521A1-20100121-C00001.png)
JPS5148532Y2 (US20100012521A1-20100121-C00001.png)
JPS5150687Y2 (US20100012521A1-20100121-C00001.png)
JPS49806A (US20100012521A1-20100121-C00001.png)
HU168620B (US20100012521A1-20100121-C00001.png)
FR2205329B1 (US20100012521A1-20100121-C00001.png)
FR2186884A5 (US20100012521A1-20100121-C00001.png)
JPS4927715U (US20100012521A1-20100121-C00001.png)
JPS4884525A (US20100012521A1-20100121-C00001.png)
JPS494044U (US20100012521A1-20100121-C00001.png)
FR2166772A5 (US20100012521A1-20100121-C00001.png)
JPS48106103U (US20100012521A1-20100121-C00001.png)
FR2172939A1 (US20100012521A1-20100121-C00001.png)
JPS49100609A (US20100012521A1-20100121-C00001.png)
JPS4915033U (US20100012521A1-20100121-C00001.png)
JPS4897709A (US20100012521A1-20100121-C00001.png)
JPS4878517A (US20100012521A1-20100121-C00001.png)
CH565381A5 (US20100012521A1-20100121-C00001.png)
CH1733573A4 (US20100012521A1-20100121-C00001.png)
CH570654A5 (US20100012521A1-20100121-C00001.png)
CH570515A5 (US20100012521A1-20100121-C00001.png)
CH568774A5 (US20100012521A1-20100121-C00001.png)

Legal Events

Date Code Title Description
ST Notification of lapse